About Us
Our Company
Our Leadership
Precision Science
Power of GPCRs
Unique & Proprietary Approach
Our Programs
Partnerships
Our Partnerships
Our Partners
News & Media
Press releases
News
Media Highlights
Downloads
Careers
Search on our website
Type Enter to start searching.
Pipeline
- page
Scroll to explore
Latest
Scroll back top
27 February 2018
Domain Therapeutics grants Bristol-Myers Squibb non-exclusive license for G protein-coupled receptor...
Discover more
6 September 2017
Domain Therapeutics and 5 SATTs announce an innovative commercial and scientific partnership to acce...
Discover more
10 May 2017
Domain Therapeutics launches dedicated bioSensAll™ website
Discover more
25 April 2017
Pfizer Inc. and Domain Therapeutics enter into a collaboration agreement on bioSensAll™
Discover more
23 January 2017
Domain Therapeutics and Merck enter into a license and collaboration agreement for development of ad...
Discover more
14 December 2016
Domain Therapeutics grants Alkermes a non-exclusive license for its G Protein-Coupled Receptor BioSe...
Discover more
18 October 2016
Domain Therapeutics and Medicxi launch Mavalon Therapeutics, aimed at halting the progression of Par...
Discover more
27 September 2016
Domain Therapeutics, Université de Montréal, IRICoR and McGill University extend licensing and par...
Discover more
29 February 2016
PeptiMimesis: New biotech startup developing next generation therapeutic peptides in immuno-oncology...
Discover more